This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints, Permissions and Rights Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Reincke, M. Search for Related Content PubMed PubMed Citation Articles by Reincke, M. Related Collections Adrenal and Hypertension Cardiovascular Endocrinology

Risk Factors Associated with a Low Glomerular Filtration Rate in Primary Aldosteronism

Medizinische Klinik Innenstadt (M.R., C.S., F.B., M.B., S.E.) and Institut für Prophylaxe und Epidemiologie der Kreislaufkrankheiten (R.L.), Ludwig-Maximilians-Universität München, 80336 München, Germany; Klinik für Nephrologie (L.C.R.), Universitätsklinikum Düsseldorf,40225 Dusseldorf, Germany; Klinische Endokrinologie (M.Q.), Charité Campus Mitte, Charité Universitätsmedizin Berlin, 10117 Berlin, Germany; Medizinische Klinik und Poliklinik I (S.H.), Julius-Maximilians-Universität, 97080 Würzburg, Germany; Endokrinologikum (S.D.), 10117 Berlin, Germany; Medizinische Klinik II (J.S.), Albert-Ludwigs-Universität, 79106 Freiburg, Germany; Institute of Epidemiology (C.M.), Helmholtz Zentrum München, 85764 Neuherberg, Germany; and Institute of Health Economics and Health Care Management (R.H.), Helmholtz Zentrum München, 85764 Neuherberg, Germany

Address all correspondence and requests for reprints to: Prof. Dr. M. Reincke, Medizinische Klinik–Innenstadt, Klinikum der Universität München, Ziemssenstr. 1, 80336 München, Germany. E-mail: martin.reincke{at}med.uni-muenchen.de.

Context: Primary aldosteronism (PA) is associated with vascular end organ damage.

Objective: We evaluated the newly established German Conn’s Registry for evidence of renal impairment and compared the data with those from hypertensive subjects of a population-based survey.

Design: We conducted a case-control study.

Patients and Controls: A total of 408 patients with PA from the Conn’s registry treated in five German centers were matched for age, sex, and body mass index in a 1:1 ratio with 408 hypertensive control subjects from the population-based F3 survey of the Kooperative Gesundheitsforschung in the region of Augsburg (KORA).

Main Outcome Measures: We measured serum creatinine and calculated glomerular filtration rate (GFR).

Results: The percentage of patients with a serum creatinine concentration above the normal range of 1.25 mg/dl was higher in patients with PA than in hypertensive controls (29 vs. 10%; P < 0.001). Regression analysis showed that age, male sex, low potassium, and high aldosterone concentrations were independent predictors of a lower GFR. Adrenalectomy reduced systolic blood pressure from a mean of 160 to 144 mm Hg. In parallel, we observed an increase in serum creatinine and a decrease of GFR from 71 to 64 ml/min (P < 0.001). A similar trend was seen after spironolactone treatment.

Conclusions: In a large cohort of patients with PA, markers of disease activity such as plasma aldosterone and serum potassium are independent predictors of a lower GFR. Specific interventions, such as adrenalectomy or spironolactone treatment, are associated with a further decline in GFR.